Researchers developed SCimilarity, a groundbreaking metric-learning framework, to rapidly analyze and compare single-cell data across tissues, diseases, and experimental conditions. This tool enables ...

50 – 80 years of age Have a 20 pack-year history of smoking (1 pack a day for 20 years or 2 packs a day for 10 years) Are a current smoker or have quit within the last 15 years If you meet the ...

Early-stage lung cancer usually refers to stages 1, 2, and 3A non-small cell lung cancer (NSCLC) as well as limited-stage small cell lung cancer (SCLC). You may have no symptoms in these early stages ...

Amgen is discontinuing a lung disease program after its investigational small molecule failed to hit any of the primary or secondary endpoints in a midstage study. The asset at play is ...

Scientists are closing in on ways to help patients grow new heart muscle after a heart attack, as well as new lung tissue to treat fibrosis, corneas to erase eye pain and other body parts to gain ...

For the last five years, Vicky Ni has been battling lung cancer — a diagnosis that came out of the blue in 2019 after she went to a doctor for pain in her shoulder. "He was taking X-rays of my ...

Body mass index trajectories from birth to early adulthood and lung function development. European Respiratory Journal , 2024; 2400298 DOI: 10.1183/13993003.00298-2024 Cite This Page : ...

Intended for use in advanced non-small cell lung cancer, BNT116 is being studied in the clinical trial to assess its safety and preliminary efficacy on a small group of patients, with a target ...

Objective response rate (ORR) of 74% across all tested dose levels of ZL-1310 in patients with recurrent extensive-stage small cell lung cancer (SCLC) -- Favorable pharmacokinetics (PK ...